by admin | Jan 30, 2022 | Insights
“In some ways, to understand how psychedelics work, you first need to understand how they don’t work. That is, they don’t work in the same way as most other available psychiatric drugs.” Another great piece by WebMD’s Paul Frysh. This article details...
by admin | Jan 29, 2022 | Insights
Another US state has moved to decriminalize the possession of psychedelics, as clinical trials continue to demonstrate their therapeutic potential. Click below to read about what this could...
by admin | Jan 29, 2022 | Insights
An update from Canada: While many have welcomed the changes to Canada’s SAP program with open arms, some advocates say the program doesn’t go far enough. #psychedelicsaroundtheworld #Canada #SAP #psychedelicscience #psilocybin #psychedelictherapy Link to...
by admin | Jan 29, 2022 | Insights
An exciting psychedelics update from the land down under: The Medical Research Future Fund (MRFF), under the Australian Government’s Innovative Therapies for Mental Illness Grant, has awarded two Sydney research teams a total of over A$3 million ($2.24 million)...
by admin | Jan 17, 2022 | Insights
#ICYMI: An interview in Psychology Today with Kelley O’Donnell, a psychiatrist and researcher who provides psychedelic-assisted psychotherapy in controlled clinical settings at NYU Langone Health’s Center for Psychedelic...
by admin | Jan 17, 2022 | Insights
“Follow the data and (don’t) get ahead of it, but at the same time, recognize it is an exciting development,” says Dr. Matthew W. Johnson, a professor of psychiatry and behavioural sciences at The Johns Hopkins University School of Medicine.A...
Recent Comments